Relapsed or Refractory Neuroblastoma
While low-risk and intermediate-risk forms of neuroblastoma may regrow (relapse) after surgery or chemotherapy, these children are usually cured with standard techniques such as surgery or chemotherapy. However, for about 10 percent of children with high-risk neuroblastoma the disease will not respond to chemotherapy (refractory). In another 40 to 50 percent of cases the disease will go away at some point but eventually relapse during or after treatment.
After spending most of her life being treated for neuroblastoma, it seemed that 18-month-old Edie had run out of options. Her family turned to The Children’s Hospital of Philadelphia, where an experimental treatment changed the course of this little girl’s life.
The Cancer Center at CHOP is top ranked in U.S. News & World Report's 2014-15 rankings of Best Children's Hospitals. Our center is also ranked number one in the nation, in Parents magazine’s 2013 report of 10 Best Children’s Hospitals.